TAK1-AMPK Pathway in Macrophages Regulates Hypothyroid Atherosclerosis

ConclusionTaken together, these data suggest that the accelerated AS in hypothyroid patients may be due to the suppression of TAK1-AMPK pathway in macrophages. This new finding may become a novel therapeutic target in hypothyroid AS.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research